眼睛应用中的粘合生物活性材料:向智能,再生和最少侵入性疗法发展
Yifei Niu1, Saiqun Li1, Fei Yu2
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong Provincial Clinical Research Center for Ocular Diseases 510060, China.
Bioactive materials
|January 6, 2026
概括
眼睛粘合剂生物活性材料提供无眼科修复,作为密封剂和药物输送系统. 这些先进的生物材料增强了组织整合,并使复杂的眼睛疾病的再生疗法成为可能.
科学领域:
- 眼科医生 眼科 眼科
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
背景情况:
- 眼睛粘合剂生物活性材料正在通过无解决方案彻底改变眼科手术.
- 这些材料作为密封剂,缺陷填充剂和配送车辆,满足眼睛环境的关键需求.
研究的目的:
- 提供对眼睛粘合剂生物活性材料的全面审查.
- 概述它们的设计策略,应用和眼科再生医学的未来方向.
主要方法:
- 根据解剖应用 (眼表面与眼底) 和原产地 (天然与合成) 的材料分类.
- 分析各种交叉连接策略,以量身定制的机械和粘合性质.
- 探索仿生设计原则和与再生疗法 (干细胞,外体细胞) 的整合.
主要成果:
- 眼部粘合剂提供增强的生物相容性,减少并发症,改善临床结果.
- 生物仿真方法提高了整合和治疗效率.
- 与再生疗法相结合,扩大了活性组织再生的潜力.
结论:
- 眼睛粘合剂生物活性材料代表了眼科手术的重大进步.
- 未来的方向集中在针对复杂的眼科挑战的个性化,可编程的再生平台上.
相关概念视频
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...


